Role of COX-2 in Tumorospheres Derived from a Breast Cancer Cell Line

被引:57
|
作者
Singh, Balraj
Cook, Kendra R.
Vincent, Laura
Hall, Carolyn S.
Martin, Cecilia
Lucci, Anthony [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 444, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
breast cancer; inflammatory breast cancer; COX-2; tumorosphere; cancer stem-like cell; disseminated tumor cell; PLURIPOTENT STEM-CELLS; IN-VITRO PROPAGATION; STEM/PROGENITOR CELLS; GENOMIC INSTABILITY; HUMAN FIBROBLASTS; BONE-MARROW; EXPRESSION; CYCLOOXYGENASE-2; PHENOTYPE; TUMOR;
D O I
10.1016/j.jss.2010.03.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Cyclooxygenase-2 (COX-2) expression in primary breast cancer predicts tumor cell dissemination to bone marrow, which is a risk factor for recurrence and distant metastasis. "Stem-like" phenotype may be important in cancer metastasis. Methods. To investigate the role of COX-2 protein in breast cancer stem-like cells, we analyzed it by co-immunofluorescence in tumorospheres derived from the MCF7 estrogen receptor-positive breast cancer cell line. To evaluate COX-2 function we utilized a COX-2 inhibitor in a clonogenicity assay performed with tumorospheres-derived cells. Results. We detected rare cells in tumorospheres (one cell per tumorosphere) with very high COX-2 expression (COX-2(high)). COX-2 transfected MCF7 cells were able to generate long-term tumorospheres culture, even though transfection efficiency was only one in a million cells. We detected expression of OCT4 in some COX-2(high) cells, supporting the hypothesis that these cells could be cancer stem-like cells. It is important that COX-2(high) cells showed less expression of Ki-67 than did neighboring cells, indicating that COX-2(high) cells may be progenitors of tumorospheres. Celecoxib inhibited the growth of tumorosphere cultures and the ability of tumorosphere-derived cells to form colonies in vitro, indicating an active role of COX-2 in these processes. However, 2 mu M celecoxib failed to eradicate tumorosphere-initiating cells. Finally, we detected rare COX-2(high) cells among SUM149 inflammatory breast cancer cells growing on plastic in serum-containing medium; the SUM149 cell line produces a very high level of COX-2 protein. Conclusion. Our results support a role for COX-2 in stem-like breast cancer cells and suggest a mechanism behind a role for COX-2 in disseminated tumor cells, which are known to exhibit characteristic biomarkers and functional properties of stem-like cells. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:E39 / E49
页数:11
相关论文
共 50 条
  • [41] Apoptotic Effects of Two COX-2 Inhibitors on Breast Adenocarcinoma Cells Through COX-2 Independent Pathway
    Norouzi, Mahnaz
    Norouzi, Shaghayegh
    Amini, Mohsen
    Amanzadeh, Amir
    Irian, Saeed
    Salimi, Mona
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2015, 116 (01) : 81 - 90
  • [42] Physiological COX-2 Expression in Breast Epithelium Associates with COX-2 Levels in Ductal Carcinoma in Situ and Invasive Breast Cancer in Young Women
    Fornetti, Jaime
    Jindal, Sonali
    Middleton, Kara A.
    Borges, Virginia F.
    Schedin, Pepper
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (04) : 1219 - 1229
  • [43] American Ginseng Inhibits Induced COX-2 and NFKB Activation in Breast Cancer Cells
    Peralta, Elizabeth A.
    Murphy, Laura L.
    Minnis, James
    Louis, Somaja
    Dunnington, Gary L.
    JOURNAL OF SURGICAL RESEARCH, 2009, 157 (02) : 261 - 267
  • [44] Correlation between COX-2 Expression and Hormone Receptors in Invasive Ductal Breast Cancer
    Lee, Jung Ah
    Bae, Jeoung Won
    Woo, Sang Uk
    Kim, Hyunchul
    Kim, Chul Hwan
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2010, 78 (03): : 140 - 148
  • [45] COX-2 Inhibitors for Cancer Treatment in Dogs
    De Nardi, Andrigo Barboza
    Morata Raposo, Talita Mariana
    Huppes, Rafael Ricardo
    Daleck, Carlos Roberto
    Amorim, Renee Laufer
    PAKISTAN VETERINARY JOURNAL, 2011, 31 (04) : 275 - 279
  • [46] Quantitative analysis of breast cancer tissue microarrays shows high Cox-2 expression is associated with poor outcome
    Zerkowski, Maciej P.
    Camp, Robert L.
    Burtness, Barbara A.
    Rimm, David L.
    Chung, Gina G.
    CANCER INVESTIGATION, 2007, 25 (01) : 19 - 26
  • [47] Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis
    Yu, Ke-Da
    Chen, Ao-Xiang
    Yang, Chen
    Qiu, Li-Xin
    Fan, Lei
    Xu, Wen-Huan
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (01) : 251 - 257
  • [48] RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression
    Bozza, William P.
    Zhang, Yaqin
    Hallett, Kory
    Rosado, Leslie A. Rivera
    Zhang, Baolin
    ONCOTARGET, 2015, 6 (32) : 32723 - 32736
  • [49] Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema
    Kashiwagi, Shinya
    Hosono, Kanako
    Suzuki, Tatsunori
    Takeda, Akira
    Uchinuma, Eiju
    Majima, Masataka
    LABORATORY INVESTIGATION, 2011, 91 (09) : 1314 - 1325
  • [50] COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro
    Du, Ye
    Shi, Aiping
    Han, Bing
    Li, Sijie
    Wu, Di
    Jia, Hongyao
    Zheng, Chao
    Ren, Liqun
    Fan, Zhimin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (04) : 1385 - 1393